Literature DB >> 30953867

Targeting drug delivery within the suprachoroidal space.

Jae Hwan Jung1, J Jeremy Chae1, Mark R Prausnitz2.   

Abstract

The suprachoroidal space (SCS), a potential anatomical space between the sclera and choroid, is a novel route for drug delivery targeting the chorioretinal layers of the eye. The safety and efficacy of SCS drug delivery have been shown in multiple clinical trials. Recent studies have developed methods for more precise targeting within the SCS at sites of action at the posterior pole (e.g., macula), near the limbus (e.g., ciliary body), and throughout the SCS using iontophoresis, swollen hydrogels, high-density particle emulsions, highly viscous and non-Newtonian fluids, and microstents. Here, we review novel technologies targeting the posterior, anterior, or entire SCS.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30953867      PMCID: PMC6708497          DOI: 10.1016/j.drudis.2019.03.027

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  49 in total

1.  Trans-scleral iontophoretic delivery of low molecular weight therapeutics.

Authors:  Sevgi Güngör; M Begoña Delgado-Charro; Begoña Ruiz-Perez; William Schubert; Phil Isom; Peyman Moslemy; Michael A Patane; Richard H Guy
Journal:  J Control Release       Date:  2010-07-23       Impact factor: 9.776

Review 2.  Iontophoresis: a non-invasive ocular drug delivery.

Authors:  Esther Eljarrat-Binstock; Abraham J Domb
Journal:  J Control Release       Date:  2005-12-15       Impact factor: 9.776

3.  Suprachoroidal silicone oil: recognition and possible mechanisms.

Authors:  A K Patel; H J Zambarakji; D G Charteris; P M Sullivan
Journal:  Eye (Lond)       Date:  2005-08-19       Impact factor: 3.775

4.  Targeted Drug Delivery Within the Eye Through the Suprachoroidal Space.

Authors:  Samirkumar R Patel; Mark R Prausnitz
Journal:  J Ocul Pharmacol Ther       Date:  2016-11-16       Impact factor: 2.671

Review 5.  In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye.

Authors:  Karen Peynshaert; Joke Devoldere; Stefaan C De Smedt; Katrien Remaut
Journal:  Adv Drug Deliv Rev       Date:  2017-09-19       Impact factor: 15.470

Review 6.  The suprachoroidal space as a route of administration to the posterior segment of the eye.

Authors:  Bryce Chiang; Jae Hwan Jung; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2018-03-12       Impact factor: 15.470

7.  Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.

Authors:  Brian C Gilger; Eva M Abarca; Jacklyn H Salmon; Samirkumar Patel
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-03       Impact factor: 4.799

8.  Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.

Authors:  B Chiang; Y C Kim; A C Doty; H E Grossniklaus; S P Schwendeman; M R Prausnitz
Journal:  J Control Release       Date:  2016-02-28       Impact factor: 9.776

9.  Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.

Authors:  Yoo C Kim; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-11       Impact factor: 4.799

10.  iStent as a Solo Procedure for Glaucoma Patients: A Systematic Review and Meta-Analysis.

Authors:  Monali S Malvankar-Mehta; Yufeng Nancy Chen; Yiannis Iordanous; Wan Wendy Wang; John Costella; Cindy M L Hutnik
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

View more
  4 in total

1.  Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting.

Authors:  Jae Hwan Jung; Sanghyun Park; J Jeremy Chae; Mark R Prausnitz
Journal:  Exp Eye Res       Date:  2019-10-01       Impact factor: 3.467

2.  Drug-Free, Nonsurgical Reduction of Intraocular Pressure for Four Months after Suprachoroidal Injection of Hyaluronic Acid Hydrogel.

Authors:  J Jeremy Chae; Jae Hwan Jung; Wei Zhu; Brandon G Gerberich; Mohammad Reza Bahrani Fard; Hans E Grossniklaus; C Ross Ethier; Mark R Prausnitz
Journal:  Adv Sci (Weinh)       Date:  2020-12-07       Impact factor: 16.806

Review 3.  Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions.

Authors:  Thales Antonio Cabral de Guimaraes; Michalis Georgiou; James W B Bainbridge; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2020-04-08       Impact factor: 4.638

Review 4.  Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases.

Authors:  Liron Naftali Ben Haim; Elad Moisseiev
Journal:  Pharmaceutics       Date:  2021-06-26       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.